Literature DB >> 17916198

Adalimumab for treatment of pyoderma gangrenosum.

R G Pomerantz, M E Husni, E Mody, A A Qureshi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17916198     DOI： 10.1111/j.1365-2133.2007.08212.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  9 in total

Review 1.  Surgical Treatment of Pyoderma Gangrenosum with Negative Pressure Wound Therapy and Skin Grafting, Including Xenografts: Personal Experience and Comprehensive Review on 161 Cases.

Authors:  Klaus Eisendle; Tobias Thuile; Jenny Deluca; Maria Pichler
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-04-28       Impact factor: 4.730

Review 2.  [Pyoderma gangrenosum].

Authors:  K Herberger
Journal:  Hautarzt       Date:  2016-09       Impact factor: 0.751

3.  Pyoderma gangrenosum: From historical perspectives to emerging investigations.

Authors:  Misty M Hobbs; Alex G Ortega-Loayza
Journal:  Int Wound J       Date:  2020-05-06       Impact factor: 3.315

4.  Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi-systematic review.

Authors:  Hakim Ben Abdallah; Karsten Fogh; Rikke Bech
Journal:  Int Wound J       Date:  2019-01-03       Impact factor: 3.315

5.  Successful use of adalimumab for treating fistulizing Crohn's disease with pyoderma gangrenosum: Two birds with one stone.

Authors:  Eva Zold; Arpad Nagy; Katalin Devenyi; Margit Zeher; Zsolt Barta
Journal:  World J Gastroenterol       Date:  2009-05-14       Impact factor: 5.742

Review 6.  Adalimumab in dermatology.

Authors:  Pawel Traczewski; Lidia Rudnicka
Journal:  Br J Clin Pharmacol       Date:  2008-07-11       Impact factor: 4.335

Review 7.  Extraintestinal Manifestations of Inflammatory Bowel Disease.

Authors:  Stephan R Vavricka; Alain Schoepfer; Michael Scharl; Peter L Lakatos; Alexander Navarini; Gerhard Rogler
Journal:  Inflamm Bowel Dis       Date:  2015-08       Impact factor: 5.325

8.  Therapy-Recalcitrant Folliculitis Decalvans Controlled Successfully with Adalimumab.

Authors:  Meshal M Alhameedy; Adel M Alsantali
Journal:  Int J Trichology       Date:  2019 Nov-Dec

9.  Adalimumab: a treatment option for pyoderma gangrenosum after failure of systemic standard therapies.

Authors:  Louisa Hinterberger; Cornelia S L Müller; Thomas Vogt; Claudia Pföhler
Journal:  Dermatol Ther (Heidelb)       Date:  2012-05-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.